Nanobac Historical Balance Sheet
| NNBP Stock | USD 0.0001 0.00 0.00% |
Trend analysis of Nanobac Pharmaceuticals Incorporated balance sheet accounts such as Accounts Payable of 616.8 K provides information on Nanobac Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Nanobac Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Nanobac Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Nanobac Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nanobac Pharmaceuticals is a good buy for the upcoming year.
Nanobac Pharmaceuticals Inventory |
|
Nanobac |
About Nanobac Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Nanobac Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Nanobac Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nanobac Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nanobac currently owns. An asset can also be divided into two categories, current and non-current.
Nanobac Pharmaceuticals Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Nanobac Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nanobac Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Nanobac Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nanobac Pharmaceuticals Incorporated are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Nanobac Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Nanobac Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Nanobac Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nanobac Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At this time, Nanobac Pharmaceuticals' Other Current Liabilities is relatively stable compared to the past year. As of 11/30/2024, Intangible Assets is likely to grow to about 4.2 M, while Accounts Payable is likely to drop slightly above 616.8 K.
| 2010 | 2011 | 2023 | 2024 (projected) | Other Current Liabilities | 82K | 876.1K | 1.0M | 1.1M | Total Assets | 5K | 7.2M | 8.3M | 7.7M |
Nanobac Pharmaceuticals balance sheet Correlations
Click cells to compare fundamentals
Nanobac Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.